Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain
- PMID: 35604206
- PMCID: PMC9241898
- DOI: 10.1128/spectrum.00041-22
Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain
Abstract
We conducted a prospective, multicenter, specific pilot study on uncomplicated urinary tract infections (uUTI). One-hundred non-duplicated uropathogenic Escherichia coli (UPEC) from uUTI occurred in 2020 in women attending 15 primary care centers of a single health region of northern Spain were characterized using a clonal diagnosis approach. Among the high genetic diversity showed by 59 different phylogroup-clonotype combinations, 11 clones accounted for 46% of the isolates: B2-ST73 (CH24-30); B2-ST73 (CH24-103); B2-ST131 (CH40-30); B2-ST141 (CH52-5); B2-ST372 (CH103-9); B2-ST404 (CH14-27); B2-ST404 (CH14-807); B2-ST1193 (CH14-64); D-ST69 (CH35-27); D-ST349 (CH36-54), and F-ST59 (CH32-41). The screening of the UPEC status found that 69% of isolates carried ≥ 3 of chuA, fyuA, vat, and yfcV genes. Multidrug resistance to at least one antibiotic of ≥ 3 antimicrobial categories were exhibited by 30% of the isolates, with the highest rates of resistance against ampicillin/amoxicillin (48%), trimethoprim (35%), norfloxacin (28%), amoxicillin-clavulanic acid (26%), and trimethoprim-sulfamethoxazole (24%). None extended-spectrum beta-lactamase/carbapenemase producer was recovered. According to our results, fosfomycin and nitrofurantoin should be considered as empirical treatment of choice for uUTI by E. coli (resistance rates 4% and 2%, respectively). We uncover the high prevalence of the pandemic fluoroquinolone-resistant ST1193 clone (6%) in uUTI, which represents the first report in Spain in this pathology. The genomic analysis showed similar key traits than those ST1193 clones disseminated worldwide. Through the SNP comparison based on the core genome, the Spanish ST1193 clustered with isolates retrieved from the Enterobase, showing high genomic similarity than the global ST1193 described in the United States, Canada and Australia. IMPORTANCE Analyzing the clonal structure and antimicrobial resistance of E. coli isolates implicated in uncomplicated urinary tract infections, one of the most frequent visits managed in primary health care, is of interest for clinicians to detect changes in the dynamics of emerging uropathogenic clones associated with the spread of fluoroquinolone resistance. It can also provide consensus concerning optimal control and antibiotic prescribing.
Keywords: Escherichia coli; ST1193; ST131; UPEC; antimicrobial resistance (AMR); fluoroquinolone resistance (FQR); uncomplicated UTI (uUTI).
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Fluoroquinolone resistance in complicated urinary tract infections: association with the increased occurrence and diversity of Escherichia coli of clonal complex 131, together with ST1193.Front Cell Infect Microbiol. 2024 Feb 27;14:1351618. doi: 10.3389/fcimb.2024.1351618. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38510968 Free PMC article.
-
[Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].Mikrobiyol Bul. 2023 Oct;57(4):535-552. doi: 10.5578/mb.20239944. Mikrobiyol Bul. 2023. PMID: 37885384 Turkish.
-
Phenotypic and Genotypic Characterization of ESBL-, AmpC-, and Carbapenemase-Producing Klebsiella pneumoniae and High-Risk Escherichia coli CC131, with the First Report of ST1193 as a Causative Agent of Urinary Tract Infections in Human Patients in Algeria.Antibiotics (Basel). 2025 May 9;14(5):485. doi: 10.3390/antibiotics14050485. Antibiotics (Basel). 2025. PMID: 40426551 Free PMC article.
-
Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0051122. doi: 10.1128/aac.00511-22. Epub 2022 Jun 6. Antimicrob Agents Chemother. 2022. PMID: 35658504 Free PMC article. Review.
-
Antibiotic Resistance Among Uropathogenic Escherichia coli.Pol J Microbiol. 2019 Dec;68(4):403-415. doi: 10.33073/pjm-2019-048. Epub 2019 Dec 5. Pol J Microbiol. 2019. PMID: 31880885 Free PMC article. Review.
Cited by
-
Draft Genome Sequence of Escherichia coli DBS1, Isolated from a Patient with Urinary Tract Infections in Morocco.Microbiol Resour Announc. 2023 Mar 16;12(3):e0058222. doi: 10.1128/mra.00582-22. Epub 2023 Feb 23. Microbiol Resour Announc. 2023. PMID: 36815766 Free PMC article.
-
Improved management of cystitis in primary care following the implementation of a simple multifaceted intervention.Aten Primaria. 2022 Nov;54(11):102493. doi: 10.1016/j.aprim.2022.102493. Epub 2022 Oct 18. Aten Primaria. 2022. PMID: 36270205 Free PMC article.
-
Dominance of Escherichia coli sequence types ST73, ST95, ST127 and ST131 in Australian urine isolates: a genomic analysis of antimicrobial resistance and virulence linked to F plasmids.Microb Genom. 2023 Jul;9(7):mgen001068. doi: 10.1099/mgen.0.001068. Microb Genom. 2023. PMID: 37471138 Free PMC article.
-
Genetic Diversity, Carbapenem Resistance Genes, and Biofilm Formation in UPEC Isolated from Patients with Catheter-Associated Urinary Tract Infection in North of Iran.Int J Clin Pract. 2022 Sep 16;2022:9520362. doi: 10.1155/2022/9520362. eCollection 2022. Int J Clin Pract. 2022. PMID: 36187911 Free PMC article.
-
Fluoroquinolone resistance in complicated urinary tract infections: association with the increased occurrence and diversity of Escherichia coli of clonal complex 131, together with ST1193.Front Cell Infect Microbiol. 2024 Feb 27;14:1351618. doi: 10.3389/fcimb.2024.1351618. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38510968 Free PMC article.
References
-
- François M, Hanslik T, Dervaux B, Le Strat Y, Souty C, Vaux S, Maugat S, Rondet C, Sarazin M, Heym B, Coignard B, Rossignol L. 2016. The economic burden of urinary tract infections in women visiting general practices in France: a cross-sectional survey. BMC Health Serv Res 16:365. doi:10.1186/s12913-016-1620-2. - DOI - PMC - PubMed
-
- Bates J, Thomas-Jones E, Pickles T, Kirby N, Gal M, Bongard E, Hood K, Francis N, Little P, Moore M, Rumsby K, Llor C, Burgman C, Verheij T, Cohen D, Wootton M, Howe R, Butler CC. 2014. Point of care testing for urinary tract infection in primary care (POETIC): protocol for a randomised controlled trial of the clinical and cost effectiveness of FLEXICULT™ informed management of uncomplicated UTI in primary care. BMC Fam Pract 15:187. doi:10.1186/s12875-014-0187-4. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical